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A T-type channel-calmodulin complex
triggers αCaMKII activation
Hadhimulya Asmara1,4, Ileana Micu2,4, Arsalan P. Rizwan1,4, Giriraj Sahu1,4, Brett A. Simms1,4, Fang-Xiong Zhang3,5,
Jordan D. T. Engbers1,4, Peter K. Stys2,4, Gerald W. Zamponi3,4,5 and Ray W. Turner1,3,4,6*
Abstract
Calmodulin (CaM) is an important signaling molecule that regulates a vast array of cellular functions by activating
second messengers involved in cell function and plasticity. Low voltage-activated calcium channels of the Cav3
family have the important role of mediating low threshold calcium influx, but were not believed to interact with
CaM. We find a constitutive association between CaM and the Cav3.1 channel at rest that is lost through an
activity-dependent and Cav3.1 calcium-dependent CaM dissociation. Moreover, Cav3 calcium influx is sufficient
to activate αCaMKII in the cytoplasm in a manner that depends on an intact Cav3.1 C-terminus needed to support
the CaM interaction. Our findings thus establish that T-type channel calcium influx invokes a novel dynamic interaction
between CaM and Cav3.1 channels to trigger a signaling cascade that leads to αCaMKII activation.
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Introduction
Calcium channels mediate a wide range of cellular func-
tions that involve activation of calcium-dependent enzymes
that can shape neuronal output [1]. Members of the Cav3
calcium channel family are designed to regulate calcium
entry in the subthreshold voltage range to control action
potential generation [2–4] and transmitter release [5–8].
Dysregulated Cav3 channels contribute to pathologies such
as epilepsy, chronic pain, and ataxia [1, 9–11]. It has been
well established that high voltage-activated (HVA) calcium
channels interact with the calcium sensing protein cal-
modulin (CaM) to regulate channel function [12–14].
Moreover, calcium entry through HVA calcium channels
can trigger a second messenger cascade by which CaM
activates Ca2+/CaM-dependent protein kinase II (CaMKII)
that can modify cell activity and long-term plasticity
[15–19]. In contrast, the Cav3 channel family is reported
to lack CaM binding consensus motifs that would permit
calcium-dependent interactions with CaM [20, 21] and
there are no reports of Cav3 calcium influx triggering a
signaling cascade for CaMKII activation. The available
data then suggest that activation of CaM-CaMKII signal-
ing by voltage-dependent calcium channels is restricted to
HVA calcium channels that open in response to large
membrane depolarizations.
We now report that under resting conditions, CaM
constitutively associates with the C-terminus of Cav3.1,
as revealed in both a heterologous expression system
and rodent brain. In response to Cav3.1-mediated calcium
influx the Cav3.1-CaM association is lost, accompanied by
phosphorylation of αCaMKII in both a heterologous
expression system and neurons in hippocampus and
cerebellum. These results are important in providing
the first evidence of a role for Cav3.1 channels in trig-
gering αCaMKII as a second messenger involved in
mediating a host of cellular functions.
Methods
Animal care and tissue dissection
Sprague-Dawley rats and C57/BL/6 mice were obtained
from Charles River and maintained according to guidelines
of the Canadian Council for Animal Care, and euthanized
according to Standard Operating Procedures defined by
the University of Calgary Animal Resource Center. All che-
micals were obtained from Sigma (Oakville, ON, Canada)
unless otherwise indicated. Animals at P19–40 were anaes-
thetized by isofluorane inhalation until unresponsive to ear
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pinch and the brain dissected out in the presence of ice
cold sucrose-cutting solution composed of (in mM): 215
sucrose, 25 NaHCO3, 20 D-glucose, 2.5 KCl, 1.25 NaH2PO4
and 3 MgCl2 preoxygenated by carbogen (95% O2, 5%
CO2) gas [22]. For coimmunoprecipitations brain tissue
was transferred to a lysis buffer medium comprised of (in
mM): 150 NaCl, 50 Tris pH 7.5, 0.5% sodium-decholic
acid, 1% NP-40, 2.5 EGTA, 0–3 CaCl2, and 1 tablet
complete protease inhibitor cocktail (EDTA free) in 10 ml,
and stored at 4 °C. A separate set of experiments prepared
brain tissue to create homogenates in different buffered
levels of calcium concentration according to Lai et al. [23].
For tissue slice histochemistry sagittal cerebellar tissue
slices of 150 μm thickness were prepared from P30-P40
male rats by Vibratome in ice-cold sucrose-cutting solution
as above. For tissue destined for recordings, slices were in-
cubated at 37 °C in artificial cerebrospinal fluid (aCSF)
composed of (mM): 125 NaCl, 1.0 KCl, 1.5 CaCl2, 1.5
MgCl2, 25 NaHCO3, and 25 D-glucose bubbled with car-
bogen gas, with a subset exposed to aCSF containing
50 mM [K]o for 10 min prior to immediate removal and
fixation for immunolabel processing. Calcium influx was
restricted to Cav3 calcium channels throughout by cutting
tissue slices and maintaining tissue in aCSF containing
30 μM Cd2+, 1 μM TTX, 10 μM DNQX and 25 μM or
100 μM DL-AP5.
Low-density cultures of hippocampal neurons were pre-
pared from P0-P1 pups of C57/BL/6 mice initially anesthe-
tized by placing on ice for 5–10 min. Dissected hippocampi
were dissociated by papain treatment and trituration and
plated on poly-L-lysine and laminin-coated glass coverslips
in 24 well culture dishes at a density of 3500–5300 cells/
cm2. After plating, cells were allowed to grow on coverslips
for 10 days in medium composed of (in mM): free neuro-
basal medium (BME), 1% B-27 supplement, 5% FBS, 0.6%
glucose, 1 Na-Pyruvate, 2 L-glutamine, 10 HEPES, 1%
Pen-strep. All cell culture chemicals were obtained from
Life Technologies (Burlington, ON, Canada).
Molecular biology
Wild-type human Cav3.1b cDNA was donated by T.
Snutch (Vancouver, BC, Canada) (GenBank accession
number AF134986.1), HA-Cav3.1 and Kir2.1 cDNA from
E. Bourinet (Institut de Génomique Fonctionnelle,
Montpellier, FR), and CaM cDNAs by J. Adelman (Vollum
Institute, OR, USA). GFP-Cav3.1 and GFP-αCaMKII were
subcloned into a GFP mammalian vector (pCMV6-AN-
GFP) (OriGene Technologies, Rockville, MD, USA) and
mKate-CaM prepared from a pmKate2-N mammalian ex-
pression vector (Axxora, Farmingdale, NY, USA). CaMKIIN
was amplified from a mouse hippocampal cDNA library
(RIKEN) and cloned into the pcDNA3.1 vector (Addgene,
Cambridge, MA, USA) [24]. To create a deletion of the C-
terminus, PCR with specific primers was performed on
Cav3.1 outside of the C-terminus region, followed by
sequencing and subcloning into the pCMV6-AN-GFP
vector (OriGene Technologies, Rockville, MD, USA) or the
pcDNA3.1 vector (Addgene, Cambridge, MA, USA) and
sequenced for final confirmation. The GFP and mKate tags
were attached to the N-terminal regions of target proteins.
To create the Cav3.1 pore mutant, a single point mutation
PCR was performed on E354K in the pore region with
the primer sequences: 5′-ACAGGTCGTTGAGCCGC-
3′, followed by sequencing and subcloning into the
pcDNA3.1 vector (Addgene, Cambridge, MA, USA)
and sequenced for final confirmation.
Transient transfection
cDNA constructs were transiently transfected into tsA-201
cells using the calcium phosphate method [25]. Coimmu-
noprecipitation experiments used 5 μg cDNA for each of
Cav3.1, HA-Cav3.1, CaM, CaM1234, and GFP-Cav3.1 lack-
ing the C-terminus (GFP-Cav3.1ΔCT). FRET studies used
1 μg cDNA of GFP-Cav3.1 and mKate-CaM, and live cell
imaging experiments and immunocytochemistry used 1 μg
Cav3.1 or Cav3.1ΔCT or Cav3.1 pore mutant, 1 μg CaM,
and 0.7 μg GFP-αCaMKII. tsA-201 were also transfected
with 0.3 μg Kir2.1 cDNA where indicated. Transfected cells
were incubated at 37 °C (5% CO2) for 24 h and then trans-
ferred to a 30 °C incubator (5% CO2) for 48–72 h prior to
imaging studies or incubated at 30 °C for 48 h before being
lysed using a buffered calcium concentration buffer for
coimmunoprecipitations.
Coimmunoprecipitation assays
tsA-201 cells transiently transfected with Cav3.1 or
Cav3.1ΔCT and either CaM or CaM1234 were lysed in a
buffer containing (in mM): 150 NaCl, 50 Tris, 2.5 EGTA,
0.5% sodium-decholic acid, 1% NP-40, 0–3 CaCl2,
pH 7.5. The nominal level of free calcium in solutions
was calculated using Maxchelator software (http://max
chelator.stanford.edu/CaEGTA-NIST.htm) to conduct
coimmunoprecipitations in the presence of different
levels of free calcium concentration ranging from 0 to
1 mM (see [23]). Brain tissue was prepared in cell lysis
buffer using a hand held glass homogenizer. Lysates
from tsA-201 cells were centrifuged at 13,000 rpm for
1 min at 4 °C and supernatants were transferred to new
tubes. Solubilized proteins were incubated with 1 μg of
rabbit anti-Cav3.1 antibody (1:1000) corresponding to
amino acid residues of the I-II linker of rat CaV3.1 [22],
or with anti-CaM antibody (1:1000; Millipore, Etobicoke,
ON, Canada) and 30 μl of Protein G beads (Life Technolo-
gies, Burlington, ON, Canada) while rotating overnight at
4 °C. Coimmunoprecipitates were washed three times with
phosphate buffered saline (PBS) in (mM): 137 NaCl, 2.7
KCl, 1 Na2HPO4, 1.8 KH2PO4, pH 7.4 reconstituted in an
equal volume of 2X loading buffer (in mM): 100 Tris, 100
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2-mercaptoethanol, 4% SDS, 0.02% bromophenol blue, 20%
glycerol, pH 6.8 and incubated at 100 °C for 5 min. Eluted
samples were loaded on 6–10% Tris-glycine gel and
resolved using SDS-PAGE. Samples were transferred to
0.2 μm PVDF membrane (Millipore, Etobicoke, ON,
Canada) and Western blot analysis performed using a
mouse monoclonal anti-CaM antibody (1:1000; Millipore,
Etobicoke, ON, Canada) or a mouse monoclonal anti-
Hemagglutinin (HA) antibody (0.4 μg; Roche, Mississauga,
ON, Canada). Secondary antibodies were conjugated to
horseradish peroxidase (HRP; 1:5000; Molecular Probes,
Eugene, OR, USA) and reacted with ECL solution (Life
Technologies, Burlington, ON, Canada).
GST-pull down assay
To prepare the GST-C-terminus of Cav3.1, we trans-
formed Cav3.1 C-terminus GST fusion protein plasmids
into BL21 and induced the expression of recombinant
proteins by 0.5 mM isopropyl-β-D-1-thiogalactopyrano-
side. GST fusion proteins were purified from bacteria
using glutathione-Sepharose 4B beads (Life Technologies,
Burlington, ON, Canada) according to the protocol rec-
ommended by the manufacturer. The GST tag was then
cleaved using Precision Protease (Life Technologies,
Burlington, ON, Canada). Complete cleavage of the
fusion protein was verified using Western blotting. The
recombinant Cav3.1 C-terminus peptides were then ap-
plied to CaM sepharose beads and incubated overnight.
The CaM sepharose beads were washed three times
with PBS, reconstituted in equal volume of loading buffer
(100 mM Tris, 4% SDS, 0.02% bromophenol blue, 20%
glycerol, 100 mM 2-mercaptoethanol, pH 6.8) and incu-
bated at 100 °C for 5 min. Eluted samples were loaded on
a 6–10% Tris-glycine gel and resolved using SDS-PAGE.
Samples were transferred to 0.2 μm PDVF membrane
(Millipore, Etobicoke, ON, Canada) and western blot
analysis was performed using a goat anti-Cav3.1 antibody
targeted to the C-terminus region of the channel (1:1000;
Santa Cruz, Dallas, TX, USA). The secondary antibody
used was a goat antibody conjugated to HRP (1:5000;
Molecular Probes, Eugene, OR, USA) and reacted
with ECL solution (Life Technologies, Burlington,
ON, Canada).
Western blot
Cerebellar tissue slices lysates of 150 μm thickness were
incubated for 10 min in any of three conditions: low
[K]o (1 mM), high [K]o (50 mM), or high [K]o with
mibefradil (1 μM) and Ni2+ (300 μM). Homogenates
were then made in the same solutions using a hand held
glass homogenizer. Eluted lysates were loaded on 6–10%
Tris-glycine gel and resolved using SDS-PAGE. Samples
were transferred to 0.2 μm PVDF membrane (Millipore,
Etobicoke, ON, Canada) and Western blot analysis
performed using a monoclonal mouse anti-αCAMKII
(1:1000; Santa Cruz, Dallas, TX, USA) or a polyclonal
rabbit anti-p-αCAMKII (Thr286) (1:1000; Santa Cruz,
Dallas, TX, USA). The secondary antibodies used were the
appropriate mouse or rabbit antibodies conjugated to
HRP (1:5000; Molecular Probes, Eugene, OR, USA) and
reacted with ECL solution (Life Technologies, Burlington,
ON, Canada).
Live cell fluorescence spectral confocal imaging
Cultured tsA-201 cells were transiently transfected with
GFP-Cav3.1 and mKate-CaM constructs for FRET imaging.
Cells were seeded onto poly-L-lysine coated 35 mm plates.
Cells were then incubated for 24 h at 37 °C and 5% CO2,
washed and replaced with colorless imaging medium (in
mM): 148 NaCl, 3 KCl, 10 HEPES, 0 or 3 CaCl2, 8 glucose,
1 MgCl2, pH 7.3 at 25 °C. Cultured cells were examined
with a Nikon Eclipse C1si spectral confocal laser-scanning
microscope with a 40×/1.3NA oil immersion objective. For
FRET imaging GFP-Cav3.1 was excited at 457 nm and
mKate-CaM at 561 nm. Emission spectra of GFP and
mKate were recorded between 400 nm to 750 nm. The
FRET signal was measured every 10 s for 450 s.
To separate the fluorescence signals of GFP and mKate
spectral images were linearly unmixed using ImageTrak
software (P.K. Stys, http://www.ucalgary.ca/styslab/image
trak) [26], collapsing a 32 channel spectral image into a
two channel image representing the integrated intensities
of GFP and mKATE fluorescence emissions. The FRET
response was quantified as follows: at each time point, the
mean pixel intensity of each fluorophore from the linearly
unmixed image within specific cellular ROIs representing
the cell cytoplasm was first calculated. The mean mKate
intensity was divided by the mean GFP intensity to yield a
ratio. Changes over time were expressed as a % change vs.
this ratio at time 0. Expressed in mathematical terms:
ΔR tð Þ ¼ FmKate tð Þ
FGFP tð Þ ‐
FmKate 0ð Þ
FGFP 0ð Þ  100%
Where:
 ΔR(t) is the % change of mKate:GFP intensity ratio
as a function of time (positive values mean an
increase in mKate emission relative to GFP, implying
greater FRET and therefore closer physical
proximity of the two fluorescent proteins).
 FmKate(t) and FGFP(t) are the mean fluorescence
intensities of the two fluorophores as a function of time
 FmKate(0) and FGFP(0) are the mean fluorescence
intensities of the two fluorophores at time 0
For tests using GFP-αCaMKII expression tsA-201 cells
were placed in colorless imaging medium comprised of
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(in mM): 148 NaCl, 1 or 50 KCl, 10 HEPES, 3 CaCl2, 8
Glucose, 1 MgCl2, pH 7.4 at 25 °C. For tests using GFP-
αCaMKII transfection of hippocampal cultures, cells
were transferred to aCSF containing 30 μM Cd2+, 1 μM
TTX, 10 μM DNQX and 25 μM or 100 μM DL-AP5.
The GFP-αCaMKII was excited at 457 nm and fluores-
cence signal in the cytoplasmic and nuclear compart-
ment of cells was measured (ImageTrak). Images were
recorded every 5 or 10 s for 250 or 400 s in control
(1 mM [K]o) and test media (50 mM [K]o), and in the
case of Fig. 4a, b, returned to aCSF containing low [K]o.
The aggregation was calculated as the change in pixel
variance of GFP fluorescence (ΔSD) presented as a per-
centage change from control variance (SD0G) to quantify
the degree of GFP-αCaMKII aggregation (ΔSD/SD0G (%))
(Figs. 4 and 6; Additional file 5: Figure S5). Alternatively,
GFP-αCaMKII aggregation was calculated as the mean
fluorescence intensity change (ΔF) presented as a change
from control mean (F0) (Figs. 5 and 7; Additional file 8:
Figure S8).
Immunohistochemistry
Tests for phosphorylation of GFP-αCaMKII and phos-
phorylation of αCaMKII were conducted on cultured
tsA-201 cells transiently transfected with cDNA, mouse
hippocampal cell cultures, and rat cerebellar tissue slices
maintained as above and exposed to control or test
conditions (1 mM or 50 mM [K]o). Cultured cells and
tissues were then quickly washed in PBS and fixed by
exposure to 4% paraformaldehyde (pH 7.4) at room
temperature for 1 h and overnight at 4 °C. The cells or
tissue were transferred to a working solution of 3% nor-
mal donkey or horse serum (Jackson Immuno-Research,
West Grove, PA, USA), 0.2% TWEEN and 2% dimethyl-
sulphoxide in phosphate buffer (PB). Primary antibodies
were reacted for 48 h at 4 °C and washed in working
solution 3 X 15 min and secondary antibodies for 4 h at
room temperature. Primary antibodies corresponded to
a monoclonal mouse anti-p-αCAMKII (Thr286) (1:500;
Life Technologies, Burlington, ON, Canada). Secondary
antibodies (1:1000) were the appropriate AlexaFluor-488
or −594 conjugated rabbit IgGs (Molecular Probes, Eugene,
OR, USA). After washing in PB, sections were mounted on
gel-coated slides, coverslipped with anti-fade medium and
stored at −20 °C. Controls consisted of omitting the pri-
mary antibodies.
Modeling
A single compartment model of Cav3 T-type calcium
channels was modified from data originally presented in
Engbers et al. [27]. The model had three conductances
including Cav3, HCN and a leak current. Cav3 current
was based on recordings from rat cerebellar Purkinje cells,
and assigned the parameters of Va −30 mV, ka −4.6, λact
3 msec; Vh: −68 mV, kh: 6.8, λinact 12 msec; ECa = 40 mV;
single channel conductance 9 pS. Parameters for IH were
Vh −80 mV, k 3, λact 200 ms; EH = −20 mV. Eleak = −77 mV.
Calcium diffusion was modeled using 10 hemispherical
compartments with radii of 20–200 nm (20 nm incre-
ments) using a calcium diffusion coefficient of 220 μm2/
msec. Simulations were run with custom made scripts in
Matlab r2016a [27].
Statistical analysis
Statistical analysis was performed using Igor software
(Wavemetrics, Lake Oswego, OR, USA) or IBM SPSS
Statistics 20 Software (Armonk, NY, USA). The homo-
geneity of variances was assessed with Levene’s and
Bartlett’s tests. Statistical significance was determined
using a paired or unpaired Student’s t-test, one-way analysis
of variance (ANOVA), or with the non-parametric multiple
comparison Dunn-Holland-Wolfe and Mann-Whitney
Wilcoxon tests as appropriate. Statistical significance was
set at p < 0.05 with * p < 0.05, ** p < 0.01, ns, not sig-
nificant. The average values are presented either as
mean ± SEM or SD as indicated.
Results
Cav3.1 coimmunoprecipitates with CaM in a calcium-
dependent manner
We tested the potential for Cav3.1 and CaM to physically
associate using coimmunoprecipitation, first performed in
the presence of a buffered calcium concentration of 100 nM
to simulate resting conditions of intracellular calcium (see
Methods). All results for coimmunoprecipitations reflect
data from 3 separate experiments. We found that Cav3.1
coimmunoprecipitated with CaM from rat brain lysate (Fig.
1a), indicating that CaM and Cav3.1 channels are part of a
protein complex. To better define the underlying molecular
determinants, we coexpressed cDNAs for CaM and Cav3.1
channels in tsA-201 cells and again were able to coimmuno-
precipitate Cav3.1 and CaM (Fig. 1b). The interaction of
CaM with Cav1.2 (L-type) calcium channels is known to
involve the C-terminus [12]. To determine the potential
involvement of the Cav3.1 C-terminus we coexpressed CaM
and a Cav3.1 mutant construct lacking the C-terminus
(Cav3.1ΔCT), and found no coimmunoprecipitation
(Fig. 1c), indicating that the C-terminus is an essential
element in a Cav3.1-CaM channel complex. To better
define if the association between Cav3.1 and CaM was
direct or indirect we used a binding assay involving
purified CaM and internal segments of the Cav3.1
channel. This analysis revealed interactions between
CaM and the Cav3.1 C-terminus, a result consistent
with a direct protein-protein interaction (Fig. 1d).
It is known that at resting levels of calcium Cav1.2
channels are preassociated with ApoCaM and that an
increase in the internal concentration of calcium leads
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to an increase in CaM binding affinity for the channel
and a structural rearrangement of the CaM channel com-
plex [13, 28–30]. To test the relative calcium dependence
of the association between Cav3.1 and CaM, we immuno-
precipitated Cav3.1 in the presence of specific levels of
buffered calcium [23]. In this way we could test for po-
tential constitutive binding of CaM in nominally zero
calcium, near resting levels of calcium in neurons
(100 nM), and in progressively higher but physiological
levels of calcium [31]. CaM coimmunoprecipitated
with Cav3.1 at 0 and 100 nM levels of calcium from
lysates of either rat brain or tsA-201 cells expressing
Cav3.1 and CaM (Fig. 1e, f ) (Additional file 1: Figure S1).
However, the Cav3.1-CaM coimmunoprecipitation was
lost in the presence of 5 μM or greater calcium concen-
trations in both rat brain and tsA-201 cells (Fig. 1e, f;
Additional file 1: Figure S1). To test if the loss of a
Cav3.1-CaM association reflects a calcium-dependent
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Fig. 1 Cav3.1 channels exhibit a calcium-dependent association with CaM. Biochemical analysis of binding interactions between Cav3.1 and CaM
using the indicated antibodies to immunoprecipitate (IP) or immunoblot (IB). The experiments are representative of at least 3 repetitions. Input
lanes reflect controls to verify the efficiency of the IP step should IB antibodies fail to reveal co-IPs. a, b Cav3.1 channels co-IP with CaM from rat
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A GST-pull down experiment between the C-terminus of Cav3.1 (CT-Cav3.1) onto CaM beads. GST-CT-Cav3.1 was grown in bacteria, and the
GST tag subsequently cleaved off as the GST non specifically bound to CaM beads. CaM beads were instead incubated with purified recombinant
Cav3.1 C-terminal peptides in the presence of 100 nM calcium and the sample eluted and run on a Western blot. The blot was probed with an
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mutant CaM1234 reveals that CaM1234 and Cav3.1 interact in the presence of 0–1 mM calcium
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interaction with CaM we coexpressed in tsA-201 cells
Cav3.1 and the calcium binding deficient CaM mutant
CaM1234, and found that CaM1234 coimmunoprecipi-
tated with Cav3.1 for all concentrations of calcium
tested (Fig. 1g).
These results indicate that the Cav3.1-CaM association
occurs preferentially in low or resting levels of calcium,
suggesting that Cav3.1 channels are constitutively associ-
ated with CaM. In contrast, there is a calcium-dependent
dissociation of CaM from the Cav3.1 channel, revealing a
process that is distinctly different from that reported
between HVA calcium channels and CaM.
Dynamics of Cav3.1 and CaM interactions revealed by
FRET
To test the dynamics of the association between Cav3.1
and CaM in an intact cellular environment, we con-
ducted FRET experiments in tsA-201 cells. For this we
created constructs of a Cav3.1 channel with GFP at-
tached to the N-terminus as a donor fluorophore (GFP-
Cav3.1) and CaM with the red fluorophore mKate
attached to its N-terminus (mKate-CaM) as an acceptor
molecule. All tests on FRET were repeated in 3-5 cell
culture plates to detect and assess emission from a large
set of Regions of Interest (ROI). Control tests established
that excitation using a 457 nm confocal laser line pro-
duced an emission profile characteristic of GFP in cells
expressing only GFP-Cav3.1 (Fig. 2a), or cells expressing
GFP-Cav3.1 together with a cDNA encoding the mKate
molecule alone (Fig. 2b). By comparison, excitation at
561 nm resulted in an emission profile for mKate in cells
transfected with mKate-CaM (Fig. 2c) as well as in cells ex-
pressing the mKate molecule and GFP-Cav3.1 (Fig. 2d). Im-
portantly, coexpressing cDNA for both GFP-Cav3.1 and
mKate-CaM allowed a single excitation line at 457 nm to
evoke a double peaked emission spectrum indicative of
FRET between GFP and mKate (Fig. 2e). We could also de-
tect single cells that exhibited only green fluorescence when
excited at 457 nm and no signal upon excitation at 561 nm,
revealing that FRET was only observed in cells that
expressed both cDNAs (Fig. 2e). These results are import-
ant in revealing that the association between Cav3.1 and
CaM under resting conditions occurs at distances that are
sufficiently close to support FRET.
Given that coimmunoprecipitation experiments indi-
cated a calcium-dependent loss of the Cav3.1-CaM band
on western blots (Fig. 1e, f ), we used FRET to further
test the calcium dependence of the Cav3.1-CaM associ-
ation in live cells (measured in all cases from defined
ROIs pooled from 3 to 6 separate experiments). Under
normal conditions, tsA-201 cells display a depolarized mem-
brane potential that leads to a voltage-dependent inactivation
of Cav3.1 calcium channels. To allow these cells to rest at a
more hyperpolarized potential we coexpressed cDNA for the
inward rectifying potassium channel Kir2.1 [32]. Coexpres-
sing Kir2.1 cDNA (0.3 μg) with GFP-Cav3.1 and mKate-
CaM promoted a resting potential of −57.2 mV ± 2.8 mV in
1 mM [K]o, and a depolarization to −24.1 mV ± 5.8 mV
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Fig. 2 Cav3.1 and CaM associate at a level that supports FRET. Fluorescence spectral confocal images of tsA-201 cells expressing constructs of
GFP-Cav3.1 (donor molecule) or mKate-CaM (acceptor molecule) excited at either 457 nm or 561 nm. Plots show the excitation (vertical line) and
the associated emission spectrum for each condition. a, b Applying excitation at 457 nm to cells expressing either GFP-Cav3.1 alone (a) or
in conjunction with the mKate acceptor molecule (b) results in a typical GFP emission spectrum. c, d Applying excitation at 561 nm to cells
expressing either mKate-CaM alone (c) or in conjunction with GFP-Cav3.1 (d) results in a pure mKate emission spectrum. e Coexpressing
GFP-Cav3.1 and mKate-CaM results in a double emission profile when excitation at 457 nm promotes FRET in a subset of cells (arrows). A
control image of the same cells excited by a 561 nm laser line at right reveals that a GFP-Cav3.1 expressing cell (arrowhead) that does not
exhibit FRET failed to express the mKate-CaM construct. All results were derived from at least 3 separate experiments. Scale bars 10 μm
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(n = 3) in the presence of 50 mM [K]o. Modeling studies of
the degree of calcium accumulation near the mouth of a
Cav3 calcium channel pore indicate peak values as high as
50 μM [33]. We repeated these studies for Cav3 current
parameters recorded from cerebellar Purkinje cells and pre-
viously modeled with respect to activation of BK potassium
channels [27]. Here the model reports an increase in
predicted [Ca]i to >35 μM at 20 nm distance, and 7 μM
at 40 nm distance from the channel pore (Additional
file 2: Figure S2) (model parameters as described previ-
ously) [27]. This is important in validating the potential
for Cav3 channels to provide the calcium necessary to
promote CaM dissociation given that the coimmuno-
precipitation between Cav3.1 and CaM was lost at
calcium concentrations of 5 μM or more (Fig. 1e, f). Using
this protocol we used the degree to which 50 mM [K]o
evoked a Cav3-mediated calcium influx that could
promote a loss of FRET between GFP-Cav3.1 and
mKate-CaM.
Controls established that under conditions of 1.0 mM
[K]o the mean level of FRET was stable over an initial
11 min period (−0.86 ± 2.63%, n = 11 ROIs) (Fig. 3a).
Exposure to high [K]o then decreased FRET within
100 s (−9.1 ± 2.12%, n = 25 ROIs, p = 0.005) (Fig. 3a).
To more carefully define the ability of Cav3.1-mediated
calcium influx to account for the loss of FRET we
substituted Cav3.1 cDNA with a GFP-Cav3.1 pore mutant
that fails to conduct calcium (Fig. 3b: Additional file 3:
Figure S3), and found that high [K]o exposure failed to
reduce FRET under these conditions (4.55 ± 1.55%, n = 8
ROIs, p = 0.24) (Fig. 3b, c). Similarly, the loss of FRET
promoted by high [K]o was blocked in the presence of the
Cav3 calcium channel blockers TTA-P2 (20 μM) (Fig. 3b,
c) (3.20 ± 4.86%, n = 8 ROIs, p = 0.58) or a combination
of mibefradil (1 μM) and Ni2+ (300 μM) (−1.4 ± 1.87%,
n = 25 ROIs, p = 0.99), or by 100 μM BAPTA-AM
(1.2 ± 0.77%, n = 21 ROIs, p = 0.99) (Fig. 3c) (Additional
file 4: Figure S4a, b). Attempts to repeat FRET measure-
ments in dissociated hippocampal cultures were unfor-
tunately not successful given a very low transfection
efficiency of GFP-Cav3.1 and mKate-CaM. This resulted in
an expression density that was too low to permit GFP exci-
tation at 457 nm, as required to elicit mKate fluorescence
as the acceptor of the GFP-mKate FRET pair. Nevertheless,
the results of FRET obtained in tsA-201 cells provide
strong evidence that a membrane depolarization that trig-
gers calcium influx through Cav3.1 calcium channels is
sufficient to induce a loss of FRET between GFP-Cav3.1
and mKate-CaM. The data are thus consistent with the re-
sults of coimmunoprecipitations as they indicate a constitu-
tive association between Cav3.1 and CaM in physiologically
low and nominally zero calcium conditions (BAPTA-AM),
and a separation of the donor and acceptor proteins when
the internal calcium concentration increased.
Cav3.1 channel-mediated calcium influx activates αCaMKII
CaM is known to activate CaMKII to act as a second
messenger involved in a wide range of functions that in-
clude gene transcription to synaptic plasticity [15, 16, 19].
Given indications that calcium influx through Cav3 chan-
nels reduced the association between Cav3.1-CaM detected
at rest, we explored the potential for CaM to activate
CaMKII in response to a depolarizing stimulus.
Activation of GFP-αCaMKII can be detected as a
change in subcellular distribution from a diffuse to an
aggregated state [17, 24]. We cotransfected tsA-201 cells
with Cav3.1 and/or GFP-αCaMKII to monitor the distri-
bution of αCaMKII at rest and following depolarization-
activated Cav3-mediated calcium influx. CaM was
coexpressed in all cells along with Kir2.1 to maintain a
hyperpolarized resting potential. The distribution of
GFP-αCaMKII was quantified by measuring the change
in pixel variance of GFP fluorescence detected in cyto-
plasmic and nuclear compartments using defined ROIs
(see Methods). Cells expressing GFP-αCaMKII and
Cav3.1 exhibited a predominantly uniform cytoplasmic
distribution in low (1.0 mM) [K]o (Fig. 4a, c). Perfusing
high (50 mM) [K]o caused the GFP-αCaMKII label to
rapidly form aggregates in the cytoplasm within 50 s
(p < 0.05 measured at 150 s, n = 3) (Fig. 4a, c). These
results are considered physiological given that the diffuse
pattern of GFP-αCaMKII distribution was stable in low
(1.0 mM) [K]o (Additional file 5: Figure S5a, b) and the
GFP-αCaMKII aggregates formed in high [K]o fully re-
versed to a diffuse distribution within 1 min upon return-
ing to low [K]o (Fig. 4a, b), as earlier reported [17].
Our ability to visualize GFP-αCaMKII aggregate
formation during live cell imaging allowed us to test
calcium-dependent events that lead to αCaMKII acti-
vation. One potential source for voltage-gated calcium
entry that triggers αCaMKII activation is that of Cav1.x L-
type calcium channels [15]. Although HVA calcium chan-
nels were not expressed in these experiments we conducted
several controls to ensure that calcium influx was restricted
to Cav3.1 channels in tsA-201 cells. First, cells expressing
GFP-αCaMKII without Cav3.1 coexpression did not exhibit
GFP-αCaMKII aggregation (Fig. 4e, f). Second, expressing a
Cav3.1 pore mutant together with GFP-αCaMKII and CaM
in tsA-201 cells fully blocked the high [K]o-evoked GFP-
αCaMKII aggregation (Additional file 5: Figure S5c, d),
despite the ability for the Cav3.1 pore mutant to conduct
calcium (Additional file 3: Figure S3). We also confirmed
that calcium influx was restricted to Cav3.1 channels by
blocking L-type calcium channels with 30 μM Cd2+
(Additional files 5 and 6: Figures S5e-h and S6), and
by finding that the high [K]o-induced aggregation of
GFP-αCaMKII was blocked by 1 μM mibefradil and
300 μM Ni2+ (Additional file 5: Figure S5g, h). High
[K]o-evoked GFP-αCaMKII aggregation was further blocked
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by 0.1 mM BAPTA-AM (Additional file 5: Figure S5i, j), in-
dicating a requirement for an increase in [Ca]i subsequent
to Cav3.1 channel activation. Together these data strongly
suggest that all voltage-gated calcium influx that lead to
αCaMKII activation in these experiments was conducted by
Cav3.1 channels.
The dependence of GFP-αCaMKII aggregation upon
calcium interactions with CaM was established by a loss
of aggregate formation in high [K]o when CaM expres-
sion was substituted with the EF hand mutant CaM1234
(Fig. 4g, h). The activation of GFP-αCaMKII is known to
require Ca2+/CaM to bind to the autoregulatory domain
of αCaMKII to promote autophosphorylation and self-
association of the αCaMKII holoenzymes into aggregates
[17, 18]. αCaMKII activity and aggregation can also be
inhibited through expression of CaMKIIN, a peptide that
binds to the catalytic pocket of αCaMKII [24, 34]. To
test if the depolarization-induced formation of GFP-
αCaMKII aggregates depended on αCaMKII phosphor-
ylation, we expressed GFP-αCaMKII and CaMKIIN in
tsA-201 cells coexpressing Cav3.1 and CaM. These tests re-
vealed that CaMKIIN blocked formation of GFP-αCaMKII
aggregates following exposure to high [K]o (Fig. 4i, j). The
outcome of these tests establish that a membrane
depolarization that triggers Cav3 channel-mediated calcium
influx activates αCaMKII through a calcium-dependent
interaction with CaM and activation of αCaMKII.
Cav3.1 calcium activation of αCaMKII depends on an
intact Cav3.1 C-terminus
It is important to define if the CaM that activates
αCaMKII reflects CaM dissociated from the Cav3.1
channel or from a presumed cytoplasmic source of
CaM subsequent to an increase in internal calcium
concentration. These two possibilities were differenti-
ated by simultaneously imaging the effects of high
[K]o exposure on GFP-αCaMKII aggregation to that of
changes in [Ca]i signaled by X-rhod-1 for cells ex-
pressing either Cav3.1 or a Cav3.1ΔCT construct that
lacked the C-terminus and thus the CaM binding site
(cf. Fig. 1c). Importantly, the Cav3.1ΔCT construct was
confirmed to form functional T-type calcium channels
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Fig. 3 The Cav3-CaM association is lost upon Cav3 channel-mediated
calcium influx. a, b Plots of FRET over time in tsA-201 cells coexpressing
GFP-Cav3.1, mKate-CaM, and Kir2.1. Cells were exposed to Low [K]o
(1 mM) or High [K]o (50 mM). a The FRET signal is stable in low
[K]o for 11 min (upper plot) but is lost within 50 s upon perfusion
of high [K]o (lower plot). b The decrease in FRET signal in high [K]o
is blocked by expressing a Cav3.1 pore mutant that does not conduct
calcium (upper plot), or 20 μM TTA-P2 (lower plot). c Bar plots of mean
measures of FRET in the indicated conditions derived from 3 to 5 plates
with 8–25 ROIs at time point 140 s. Mibefradil (Mib) 1 μM, Ni2+ 300 μM,
BAPTA-AM 100 μM. Average values are mean ± SEM. * p < 0.05, **
p < 0.01, ns, not significant
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(Additional file 7: Figure S7) that supported accumulation
of intracellular calcium upon exposure to high [K]o (Fig. 5).
Here we found that high [K]o-induced GFP-αCaMKII
aggregation was blocked in cells expressing Cav3.1ΔCT but
not Cav3.1, despite an equivalent increase in calcium fluor-
escence of X-rhod-1 (Fig. 5). These results are import-
ant in establishing that αCaMKII activation is mediated
by Cav3.1-dependent calcium entry that requires the pres-
ence of a channel region capable of associating with CaM.
Cav3 calcium influx triggers αCaMKII phosphorylation in
neurons
To determine if the Cav3.1-CaM-αCaMKII signaling
cascade could be detected in neuronal populations we
transiently transfected GFP-αCaMKII and Cav3.1 into
dissociated cultures of hippocampal neurons. This test
revealed a similar diffuse cytoplasmic distribution of
GFP-αCaMKII fluorescence as found for tsA-201 cells in
low levels of [K]o (Fig. 6a, b). But upon perfusion of high
Fig. 4 Cav3 channel-mediated calcium influx leads to αCaMKII aggregation. tsA-201 cells are cotransfected with GFP-αCaMKII, CaM, Cav3.1, and
Kir2.1 and exposed to low [K]o (1.0 mM) or high [K]o (50 mM). Plots of the mean pixel variance of GFP-αCaMKII fluorescence in ROIs in the cytoplasm
and nuclear regions shown at right. a, b In cells coexpressing Cav3.1 GFP-αCaMKII exhibits a diffuse cytoplasmic distribution in low [K]o that changes
to aggregates in high [K]o, a pattern that is fully reversible upon returning to low [K]o. c, d Magnified images of the distribution of GFP-αCaMKII in low
[K]o and after perfusing high [K]o, with plots indicating a restriction of clusters primarily to cytoplasm and peri-nuclear regions. e-i Formation
of GFP-αCaMKII aggregates induced by high [K]o is prevented in cells lacking Cav3.1 (e, f), and blocked by substitution of CaM with CaM1234
(g, h), or by coexpression of CaMKIIN (0.3 μg) as an inhibitor of αCaMKII phosphorylation (i, j). Values are mean ± SD derived from n = 3 plates
with 12–29 ROIs. Scale bars 10 μm.* p < 0.05
Asmara et al. Molecular Brain  (2017) 10:37 Page 9 of 15
[K]o (50 mM) there was a substantial increase in the
number of GFP-αCaMKII aggregates in the cytoplasm
within 1.5 min (Fig. 6c, d). The aggregation of GFP-
αCaMKII in high [K]o was again blocked in the presence
1 μM mibefradil/300 μM Ni2+ (Fig. 6e, f ).
The above results are important in indicating that
Cav3.1-mediated calcium influx can mediate aggregation
of GFP-αCaMKII in neurons, a process that tests in
tsA-201 cells indicated should involve αCaMKII phos-
phorylation. To visualize the activation of phosphory-
lated αCaMKII we used immunolabel detection for
pαCaMKII in both hippocampal cell cultures and cerebellar
tissue slices exposed to 10 min of high [K]o (50 mM)
medium in the presence or absence of mibefradil/Ni2+
(Fig. 7) (Additional file 8: Figure S8). Calcium influx
was restricted to Cav3 calcium channels by conducting
tests in medium containing 30 μM Cd2+, 10 μM DNQX,
25 μM or 100 μM DL-AP5, and 1 μM TTX, and tissues
fixed for immunocytochemistry within 10 min after the
high [K]o treatment. Under resting conditions of 1 mM
[K]o hippocampal cell cultures and cerebellar tissue slices
exhibited little if any detectable immunolabel for pαCaM-
KII (Fig. 7a–g). When exposed to high [K]o for 10 min
hippocampal cells exhibited an increase in pαCaMKII
immunolabel that highlighted cell somata and surround-
ing processes (Fig. 7b, g). Exposure of cerebellar tissue
slices to high [K]o revealed an increase in pαCaMKII
labeling in Purkinje cell bodies (Fig. 7e, g). The high
[K]o-induced increase in pαCaMKII was again blocked
in the presence of 1 μM mibefradil and 300 μM Ni2+
for both hippocampal cultures and cerebellar tissue
slices (Fig. 7c, f, g). We also found a significantly re-
duced level of pαCaMKII immunolabel if hippocampal
cultures were pre-exposed to a peptide inhibitor specific
for pαCaMKII (AIP 10 μM; n 3–4, p < 0.01) (Additional
file 8: Figure S8).
To complement the immunolabeling tests we further
examined pαCaMKII protein density in cerebellar tissue
slices exposed to low [K]o or high [K]o in the presence
or absence of mibefradil/Ni2+-containing medium. Tissue
was lysed in a medium containing the same final solution
and prepared for Western blot analysis. In each case a
band for pαCaMKII was detected, but the ratio of band
densities (pαCaMKII/αCaMKII) was significantly greater
for tissue exposed to high [K]o (n = 3; p < 0.05), a differ-
ence that was not present in tissues preexposed to mibe-
fradil/Ni2+ (Fig. 7h).
Discussion
CaM is known to establish an association with HVA
calcium channels to provide feedback regulation of
channel activity or downstream activation of CaMKII.
The current study is important in showing that the
Cav3.1 calcium channel exhibits a novel calcium-dependent
interaction with CaM that also triggers CaM-dependent ac-
tivation and phosphorylation of αCaMKII. Moreover, Cav3-
mediated interactions can be detected in both tsA-201 cells
as well as hippocampal cerebellar neurons.
CaM association with Cav3.1 channels
The complexity and wealth of interactions that define
CaM binding and modulation of HVA calcium channels
have emerged over many years of work. An HVA calcium
channel (e.g. Cav1.x) generally forms a pre-association
with calcium free ApoCam at resting levels of internal
calcium concentration, and a calcium-dependent increase
in CaM binding affinity [13, 28–30]. The assays conducted
here reveal that Cav3.1 channels exhibit a constitutive
association with ApoCam at resting levels of calcium. The
occurrence of FRET between Cav3.1 and CaM at resting
levels of internal calcium confirms a close protein-protein
interaction given that FRET requires two molecules to be
positioned within 10–100 Å distance. CaM binding to
HVA calcium channels involves at least an IQ domain on
the calcium channel C-terminus, as well as an NSCaTE
domain on the N-terminus [13, 35–40]. The amino acid
sequence of the Cav3.1 C-terminus does not appear to
present a clear IQ domain as defined for HVA channels,
Fig. 5 Cav3.1-mediated activation of αCaMKII depends on an intact
Cav3.1 C-terminus. tsA-201 cells are transfected with Cav3.1 or a
Cav3.1 mutant lacking the C-terminus (Cav3.1ΔCT) to remove a site
for preassociation of CaM with the Cav3.1 channel and preloaded
with 2 μM X-rhod-1 to detect changes in [Ca]i. Cells are maintained
at rest in low [K]o (1 mM) or exposed to 10 min of high [K]o (50 mM),
with all medium containing 30 μM Cd2+ to block HVA calcium channels.
The extent and timecourse of a shift in GFP-αCaMKII distribution from
diffuse to aggregates in the cytoplasm is compared to that of a change
in fluorescent intensity of X-rhod-1 relative to the mean of control
baseline (ΔF/F0). High [K]o increased [Ca]i to an equivalent relative
level in cells expressing either Cav3.1 or Cav3.1ΔCT but GFP-αCaMKII
aggregation is blocked in cells expressing the Cav3.1ΔCT mutant. The
distribution of GFP-αCaMKII is measured as density for at least 25–34
ROIs from 4 to 5 plates. Values are mean ± SEM derived from n = 4–5
plates with 25–34 ROIs
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nor does it exhibit a canonical CaM binding motif. Our
work establishes that the Cav3.1 C-terminus is required
to detect a coimmunoprecipitation between CaM and
Cav3.1, with GST pull down assays supporting a direct
interaction between CaM and the C-terminal region.
The precise amino acid residues on the C-terminus
responsible for the Cav3.1-CaM interaction remain to
be determined.
The Cav3.1-CaM association is further distinguished
from CaM-HVA calcium channel interactions in that
membrane depolarization promotes a loss of FRET
between Cav3.1 and CaM. We note that a loss of FRET
could reflect a repositioning of CaM on the Cav3.1
channel, however, the loss of coIP between Cav3.1 and
CaM at [Ca] greater than 1 μM indicates a physical dissoci-
ation. Moreover, Cav3.1 calcium influx proves to be suffi-
cient to promote Cav3.1-CaM dissociation, as established
by preventing the depolarization-induced loss of FRET
using Cav3 calcium channel blockers or by expressing a
non calcium-conducting Cav3.1 channel pore mutant.
These findings are important in revealing a dynamic
interaction between Cav3.1 and CaM that is essentially
opposite to that of HVA calcium channels.
αCaMKII activation
Calcium influx can activate multiple forms of CaMKII that
translocate to perinuclear compartments [15, 18, 41–47],
with the current work addressing αCaMKII. Activation of
αCaMKII has been traced to calcium influx via specific HVA
calcium channels in different cell types [15, 17, 18, 24, 44].
The current study is the first to reveal an interaction
between Cav3.1 calcium influx and subsequent activa-
tion of αCaMKII. An important question is the extent
to which αCaMKII is activated specifically by CaM
Fig. 6 GFP-αCaMKII clustering in transfected neurons. Neurons are cotransfected with GFP-αCaMKII and Cav3.1 (unlabeled) and exposed to low
[K]o (1.0 mM) or high [K]o (50 mM). a-d A diffuse distribution of αCaMKII-GFP is stable in low [K]o over time (a, b), with high [K]o promoting aggregation
of GFP-αCaMKII (c, d). e, f Formation of GFP-αCaMKII aggregates induced by high [K]o is blocked in the presence of mibefradil (1 μM) and Ni2+ (300 μM).
g Bar plots of the mean pixel variance of GFP-αCaMKII fluorescence for the tests in (a-f). Values are mean ± SD derived from n = 3 plates with 5–10 ROIs.
Scale bars 10 μm.* p < 0.05
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molecules that are preassociated with Cav3.1 under
resting conditions and dissociate upon channel open-
ing, as opposed to CaM activated in the cytoplasm sub-
sequent to a Cav3.1-mediated increase in [Ca]i. A role
for CaM that dissociates from the Cav3.1 channel was
supported by our finding that expression of a Cav3.1
mutant lacking the C-terminus (removing the CaM
binding site) blocked depolarization-induced GFP-
αCaMKII aggregation despite an equivalent elevation of
[Ca]i as found with intact Cav3.1 channels (Fig. 5).
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Fig. 7 Cav3 calcium influx triggers αCaMKII phosphorylation in neurons. a-f Confocal images of cultured mouse hippocampal cells (a-c), and rat
cerebellar tissue slices (d-f). Activated αCaMKII is identified by using a phospho-αCaMKII (pαCaMKII) antibody with additional DAPI label for nuclear
staining in (a-c). Each preparation was maintained at rest in low [K]o (1 mM) or exposed to 10 min of high [K]o (50 mM) prior to fixation within
10 min of the end of high [K]o exposure. All results were derived from at least 3 separate experiments. In all neuronal cell tests calcium influx is
restricted to Cav3 channels by maintaining cells in 30 μM Cd2+, 10 μM DNQX, 25 μM DL-AP5, and 1 μM TTX. a, b In hippocampal cell cultures
high [K]o induces pαCaMKII labeling. d, e In cerebellar tissue slices high [K]o induces pαCaMKII labeling in Purkinje cell bodies. c, f High [K]o-
induced labeling for pαCaMKII is blocked in both hippocampus (c) and cerebellum (f) in the presence of Cav3 channel blockers 1 μM mibefradil and
300 μM Ni2+. Dashed lines in (d-f) depict the boundaries of the Purkinje cell body layer. g Bar plots of the mean intensity of pαCaMKII fluorescence in
hippocampal cell cultures and Purkinje cells in cerebellar tissue slices for panels (a-f) were quantified using ImageTrak software. Scale bars 10 μm. Values
are mean ± SEM derived from n = 3–4 coverslips with 30–130 ROIs. h Western blot analysis to test the relative density of αCaMKII and p-αCaMKII labeling
in cerebellar slice lysates in low or high [K]o, with mean bar plots of the band density ratio (pαCaMKII/αCaMKII) (Image J software). The high [K]o lysate has
a higher band density than either low [K]o or high [K]o in the presence of mibefradil and Ni2+. Values are mean ± SEM derived from 3 separate experiments.
* p < 0.05;** p < 0.01. PC, Purkinje cell layer; mol, molecular layer; gran, granule cell layer
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Others have shown that pH can augment calcium-
dependent clustering of GFP-αCaMKII [17] so it is pos-
sible that this could contribute to our effects. But the
current study establishes that calcium influx through
the Cav3 channel class can initiate the steps that lead to
an aggregation of GFP-αCaMKII that is fully reversible.
In neurons, synaptic stimulation induces long term
changes in synaptic efficacy that involves CaMKII activa-
tion and translocation to perinuclear or synaptic regions
[17, 46, 48, 49]. In this regard we found that exposure to
high [K]o invoked a substantial increase in the number
of GFP-αCaMKII aggregates in the cytoplasm of hippo-
campal neuronal cultures, and of pαCaMKII labeling in
processes of cultured hippocampal neurons and in cere-
bellar Purkinje cell bodies. Moreover, all these effects were
blocked by exposure to Cav3 channel blockers. These data
verify that Cav3 channel-triggered activation of αCaMKII
occurs in neuronal circuits known to exhibit long-term
plasticity of synaptic function, including Cav3-mediated
forms of LTP in cerebellar neurons [50, 51].
Thus, the sequence of events identified for Cav3.1-
CaM-αCaMKII interactions differs from that of HVA
calcium channels, revealing separate pathways to activate
αCaMKII. A Cav3-initiated process is also distinct in
that Cav3.1 channels can be activated over a larger volt-
age range than HVA calcium channels. Cav3.1-mediated
activation αCaMKII may then be prominent in certain
cell types or brain regions where these channels regulate
cell excitability at even subthreshold potentials. However,
we note that αCaMKII activation by way of Cav3.1 or
HVA channel calcium influx is not mutually exclusive.
Rather, we interpret these results as evidence that Cav3
calcium influx is sufficient to activate αCaMKII through
a novel interaction with CaM, providing a means to
complement the role for HVA calcium channels in trig-
gering αCaMKII activation.
Additional files
Additional file 1: Figure S1. Cav3.1 channels exhibit a calcium-dependent
association with CaM. a, b. Tests for coimmunoprecipitation between Cav3.1
channels and CaM from rat brain lysate (a) or homogenates of tsA-201 cells
coexpresssing Cav3.1 and CaM (b) in the presence of the indicated buffered
levels of calcium. Cav3.1 coimmunoprecipitates with CaM in 0 and 100 nM
calcium but not at 50 μM or 1 mM calcium. All results were derived from at
least 3 separate experiments. (PDF 828 kb)
Additional file 2: Figure S2. A model of Cav3.1 channel conductance
and increase in [Ca]. a. Plots of the voltage-dependence for activation
(blue line) and inactivation (orange line) derived from steady-state voltage
commands from whole-cell recordings of Cav3 current in Purkinje cells
(modified from Engber et al. [27]. b. Calculated changes in internal
calcium concentrations for a hemispherical compartment around the
calcium source for a Cav3 channel with a single channel conductance of
9 pS. Voltage commands are applied from a holding potential of −75 mV
in 10 mV steps to +10 mV and calcium internal concentration changes
plotted for distances of 20 nm and 40 nm distance from a Cav3 channel,
leading to a peak calcium concentration of 36 μM (20 nm) and 7 μM
(40 nm) for a step to – 20 mV. (PDF 349 kb)
Additional file 3: Figure S3. Cav3.1 channel pore mutant constructs. A
single amino acid mutation of Cav3.1 creates a pore mutant that does
not conduct calcium current. Shown are representative recordings and
the associated I-V plot of a transient low voltage-activated current measured
in the Cav3.1 mutant expressed in tsA-201 cells. Superimposed recordings and
plot illustrate the records obtained in normal bathing medium and following
substitution of sodium in the bathing medium by 130 NMDG. (PDF 351 kb)
Additional file 4: Figure S4. Block of high [K]o-mediated loss of GFP-
Cav3.1 - mKate-CaM FRET. Plots of the FRET signal over time in tsA-201
cells coexpressing GFP-Cav3.1 and mKate-CaM. Values are normalized to
the mean value of all fluorescence measurements in the time period. a, b.
Cells were exposed to Low [K]o (1 mM) or High [K]o (50 mM). A loss of FRET
encountered upon exposure to high [K]o is prevented by the Cav3 channel
blockers 1 μM mibefradil and 300 μM Ni2+ (a) and in the presence of
0.1 mM BAPTA-AM (b). Average values are mean ± SEM. (PDF 337 kb)
Additional file 5: Figure S5. Activation of αCaMKII depends on Cav3.1
calcium influx and an increase in [Ca]i. The distribution of GFP-αCaMKII
tested in tsA-201 cells in low [K]o (1 mM) or high [K]o (50 mM) and indicated
reagents. All cells are cotransfected with CaM and Kir2.1. Plots indicate mean
pixel variance of fluorescence in ROIs in cytoplasm and nuclear regions. a, b.
A diffuse distribution of αCaMKII-GFP is stable in low [K]o over time. c-h. The
aggregation of αCaMKII-GFP depends on Cav3.1-mediated calcium influx, as
shown when a Cav3.1 pore mutant (Cav3.1 PM) that does not conduct
calcium is expressed (c, d), the ability for high [K]o to promote aggregation in
the presence of 30 μM Cd2+(e, f) but not in the presence of mibefradil (1 μM)
and Ni2+ (300 μM) (g, h). i, j. The dependence of αCaMKII-GFP aggregation
induced by high [K]o exposure also depends on an increase in [Ca]i in being
blocked by pre-expossure to BAPTA-AM (0.1 mM). Values are mean ± SD
at 250 s derived from 3 to 4 plates with 14–19 ROIs. Scale bars 10 μm.
(PDF 5411 kb)
Additional file 6: Figure S6. Selective block of Cav1 L-type calcium
channels by external Cd2+. a, b. Shown are representative recordings of
calcium current evoked in tsA-201 cells expressing either the Cav1.2 or
Cav1.3 calcium channel isoforms (a) or Cav3.1 calcium channels (b), with
associated mean I-V plots shown below. Perfusing 30 μM Cd2+ blocks
both Cav1.2 and Cav1.3 channel isoforms (a) but not Cav3.1 (b). For CaV1.2
channel expression included 2 μg each of human- α1C-PMT2, α2δ1-PMT2 and
β1B-PMT2. For CaV1.3 channel expression 2 μg each of human- α1D-GFP37−,
α2δ1-pcDNA and β1B-pcDNA was used. CaV1.2 and CaV1.3 expressing cells
were co-transfected with 100 ng eGFPN1 for identification of transfected
fluorescence cells. Average values are mean ± SEM. (PDF 572 kb)
Additional file 7: Figure S7. Calcium conductance of Cav3.1 channel
construct lacking the C-terminus. Representative recordings and I-V plot
of T-type calcium current for a Cav3.1 channel construct lacking the C
terminal region (Cav3.1ΔC), removing a key site for CaM association.
Average values are mean ± SEM. (PDF 343 kb)
Additional file 8: Figure S8. Cav3-mediated activation of αCaMKII. Bar
plots of the mean fluorescence intensity of pαCaMKII in cultured
hippocampal cells in low [K]o (1 mM) and following exposure to
10 min of high [K]o (50 mM) prior to fixation within 10 min of the end
of high [K]o exposure. Calcium influx is restricted to Cav3 channels by
maintaining cells in 30 μM Cd2+, 10 μM DNQX, 100 μM DL-AP5, and
1 μM TTX. Labeling for pαCaMKII in the cytoplasm increases in high
[K]o that is reduced by a peptide inhibitor specific for pαCaMKII (AIP
10 μM). Fluorescence intensity was quantified in ImageTrak software (see
Methods). Values are mean ± SEM derived from n = 3–4 cover slips from at
least 3 separate experiments with 29 ROIs. ** p < 0.01. (PDF 290 kb)
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